Acute ST-segment elevation myocardial infarction is estimated to occur in more than 500,000 people in the US every year. With the introduction of reperfusion therapy by fibrinolysis or primary ...

Emerging evidence suggests that bone-marrow-derived stem and progenitor cells can be used to improve cardiac function after acute myocardial infarction. We tested this concept in the randomized, ...

A number of substudies have been published in 2007, including a Focus Issue of JACC highlighting additional findings from ExTRACT-TIMI 25. In ExTRACT-TIMI 25, women presented with a profile of higher ...

Successful reperfusion following ST-segment elevation myocardial infarction (STEMI) can be achieved using either pharmacologic or mechanical interventions. The goal of reperfusion therapy is to ...

Researchers at University Medical Center Maastricht and international partners report that a single shot of the drug zalunfiban given at first medical contact for suspected ST-elevation myocardial ...

The incidence of no-reflow was significantly higher in the thrombectomy group (1.4% vs 0.2%), which researchers attributed to ...

Heart attack death rates rose by 1.2% among adults younger than age 55 who were hospitalized between 2011 and 2022 with a first severe heart attack, according to a February study published in the ...

An inferior myocardial infarction results from occlusion of the right coronary artery (RCA). This can cause a ST elevation myocardial infarction or a non-ST segment elevation myocardial infarction.

myocardial infarction, heart attack Even patients with advanced CKD or receiving dialysis appear to benefit from guideline-directed STEMI therapies, according to a retrospective study. Patients with ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

A 44-year-old man presented with severe chest pain and dizziness to the nursing post where he worked in Coral Bay, Australia, more than 1000 km from Perth and 150 km from the next nearest medical ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...